Inquiaroma expands the possibilities of creatine with CreaStab™

The company incorporates into its portfolio this microencapsulated creatine monohydrate solution, developed by Zeus Hygia Life Sciences, which seeks to improve the stability of the ingredient and facilitate its application in new categories and formats

26 of August of 2026
Save
CreaStab™
CreaStab™

Creatine continues to gain ground beyond sports nutrition and opens new opportunities in segments such as active wellness, healthy aging, energy, and functional formulations. In this context, Inquiaroma presents CreaStab™, a solution based on microencapsulated creatine monohydrate that the company distributes and that has been developed by its partner Zeus Hygia Life Sciences.

The main contribution of CreaStab™ lies in its ability to improve the stability of creatine during processing and throughout the product's shelf life. Conventional creatine monohydrate can present difficulties in acidic conditions or when subjected to high-temperature processes, which can limit its use in certain matrices.

The microencapsulation technology allows CreaStab™ to maintain greater stability even under demanding conditions. According to information provided by Inquiaroma, the ingredient withstands processes at temperatures between 130 and 150 ºC and shows superior stability in acidic media, including pH 2.0 and pH 4.0.

This feature expands the possibilities for manufacturers looking to incorporate creatine into formats other than traditional powder, especially in liquid products and other complex formulations. Its possible applications include functional beverages, ready-to-drink (RTD), gummies, capsules, protein bars, and chewable formats.

In addition to stability, CreaStab™ seeks to improve the consumption experience. Microencapsulation technology helps reduce the bitterness and sandy mouthfeel associated with certain creatine formulations, facilitating the development of products with a more attractive sensory experience.

For Inquiaroma, the proposal responds to the evolution of the creatine market, whose consumption is extending to new use occasions and categories. The company points out that this expansion is generating opportunities to develop functional products capable of integrating the ingredient into more convenient, versatile formats adapted to new consumer demands.

With CreaStab™, Inquiaroma thus reinforces its portfolio of functional ingredients with a solution aimed at overcoming some of the technological barriers of conventional creatine and facilitating its incorporation into a new generation of sports nutrition and nutraceutical products.